Feature Channels: Drug Resistance

Filters close
Released: 2-Jan-2024 4:05 PM EST
دراسة تظهر أن الجزيئات المناعية قد يكون لها دورًا رئيسيًا في تطور مرض التصلُّب الجانبي الضموري (ALS)
Mayo Clinic

حدد الباحثون والمتعاونون في مايو كلينك بروتينًا تفرزه الخلايا المناعية والذي قد يقوم بدورٍ رئيسيٍ في ظهور مرضالتصلُّب الجانبي الضموري، المعروف أيضًا باسم مرض لو غيريغ. ووجد الفريق أيضًا أن العلاج التعديلي المناعي الذي يقوم بعملية إِحْصار للبروتين يمكنه استعادة الوظيفة الحركية في النماذج قبل السريرية. وتشير النتائج إلى أن البروتين، المعروف باسم أ5 إنتغرين (الذي يُنطق ألفا 5 إنتغرين)، هو مستهدف علاجي محتمل لعلاج مرض التصلُّب الجانبي الضموري.

Released: 2-Jan-2024 3:05 PM EST
Un estudio muestra que una molécula del sistema inmunitario puede desempeñar un rol clave en la evolución de la ELA
Mayo Clinic

Los investigadores y colaboradores de Mayo Clinic han identificado una proteína expresada en células inmunitarias que podría desempeñar un rol clave en el desarrollo de la esclerosis lateral amiotrófica (ELA), también conocida como enfermedad de Lou Gehrig. El equipo también descubrió que un tratamiento inmunomodulatorio que bloquea la proteína era capaz de restaurar la función motriz en modelos preclínicos. Los hallazgos indican que la proteína, conocida como integrina α5 (pronunciado integrina alfa 5), es un posible blanco terapéutico para la ELA.

Released: 2-Jan-2024 3:05 PM EST
Estudo mostra que molécula imunológica pode desempenhar uma função fundamental na progressão da ELA
Mayo Clinic

Pesquisadores e colaboradores da Mayo Clinic identificaram uma proteína que é expressa por células imunológicas que pode desempenhar uma função importante no desenvolvimento daesclerose lateral amiotrófica (ELA), também conhecida como doença de Lou Gehrig. A equipe também descobriu que um tratamento imunomodulador que bloqueia a proteína conseguiu restaurar a função motora em modelos pré-clínicos. As descobertas sugerem que a proteína, conhecida como integrina α5 (pronunciada como integrina alfa 5), é um possível alvo terapêutico para ELA.

Released: 20-Dec-2023 3:05 PM EST
Working with Big Data requires a lot of power! The latest research and features on Supercomputing
Newswise

With the rise in machine learning applications and artificial intelligence, it's no wonder that more and more scientists and researchers are turning to supercomputers. Supercomputers are commonly used for making predictions with advanced modeling and simulations. This can be applied to climate research, weather forecasting, genomic sequencing, space exploration, aviation engineering and more.

       
Released: 19-Dec-2023 7:05 AM EST
Breakthrough in the development of a drug for sleeping sickness
Bar-Ilan University

Damage to the protein production capacity neutralizes the trypanosome parasite, which causes sleeping sickness. Joint research by Prof.

Newswise: Medicare is Overpaying for Generic Drugs
Released: 5-Dec-2023 10:00 AM EST
Medicare is Overpaying for Generic Drugs
University of California San Diego

Researchers from at University of California San Diego, West Health, and the University of Washington have found evidence that the private insurers that sponsor Medicare Part D are artificially inflating the costs of certain generic drugs by overpaying pharmacies.

Newswise: Could Our Body’s “Bleach” Be Key to Fighting a Common Fungal Pathogen?
Released: 4-Dec-2023 1:05 PM EST
Could Our Body’s “Bleach” Be Key to Fighting a Common Fungal Pathogen?
Stony Brook University

A study that assesses the effects of hypochlorous acid (HOCI), commonly known as bleach, as it is generated during the immune response of a cell (phagocytosis) when fighting a common fungal pathogen, Candida albicans, reveals that HOCI is a potent killing agent. The laboratory finding is highlighted in the journal mBio.

Newswise: Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
4-Dec-2023 8:00 AM EST
Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Many of the most potent human oncoproteins belong to a class of proteins called transcription factors, but designing small molecule drugs that target transcription factors is a major challenge.

1-Dec-2023 11:00 AM EST
One in Six Patients with Opioid Use Disorder Leaving the Hospital Before Completing Treatment, Potentially Due to Untreated Withdrawal Symptoms
Perelman School of Medicine at the University of Pennsylvania

The number of patients admitted with opioid use disorder (OUD) and injection-related infections who left the hospital before completing treatment increased significantly between 2016 and 2020 (from 9.3 percent to 17 percent) according to analysis from researchers at the Perelman School of Medicine at the University of Pennsylvania.

Released: 29-Nov-2023 10:05 AM EST
Drugs already licensed could be trialled to potentially treat secondary brain cancer, new research finds
University of Bristol

The largest review of papers for brain cancer that has spread from the lungs has found abnormalities in the brain cancer and for which licensed drugs could be clinically trialled to find out if they could treat the disease.

Newswise: Turning Drug Resistance Against Itself
Released: 26-Nov-2023 11:00 AM EST
Turning Drug Resistance Against Itself
Stony Brook University

A team of Stony Brook University researchers led by Gábor Balázsi, PhD, have been testing drug resistance with mammalian cell lines. Their latest investigation reveals that by taking a part of a DNA amplification from a cell, which causes resistance, and placing it back in, actually stops the drug resistance. Their findings will be published this week in PNAS.

Newswise: Making sense of bacterial Babel
Released: 23-Nov-2023 5:05 AM EST
Making sense of bacterial Babel
Aalto University

Researchers tease apart the relationships between bacterial languages

Newswise: ASPET Welcomes the 2023 FASPET Class
Released: 21-Nov-2023 4:00 PM EST
ASPET Welcomes the 2023 FASPET Class
Federation of American Societies for Experimental Biology (FASEB)

The American Society for Pharmacology and Experimental Therapeutics (ASPET) has selected 16 individuals as 2023 ASPET Fellows.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Released: 20-Nov-2023 7:05 PM EST
Genomic study links cannabis abuse to multiple health problems
Yale University

A Yale-led analysis of the genomes of more than 1 million people has shed light on the underlying biology of cannabis use disorder and its links to psychiatric disorders, abuse of other substances such as tobacco, and possibly even an elevated risk of developing lung cancer.

Released: 18-Nov-2023 1:05 PM EST
Study reveals surprising link between malnutrition and rising antibiotic resistance
University of British Columbia

University of B.C. researchers have uncovered startling connections between micronutrient deficiencies and the composition of gut microbiomes in early life that could help explain why resistance to antibiotics has been rising across the globe.

Newswise: First human clinical trial for pill-sized device that monitors breathing from the gut
Released: 18-Nov-2023 1:05 PM EST
First human clinical trial for pill-sized device that monitors breathing from the gut
Cell Press

Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool, described November 17 in the journal Device, has the potential to provide accessible and convenient care for people at risk of opioid overdose.

Newswise: Cheap medicines prevented migraine as well as expensive ones
Released: 18-Nov-2023 1:05 PM EST
Cheap medicines prevented migraine as well as expensive ones
University of Bergen

Migraine is more than just a headache. Often the pain is accompanied by nausea, vomiting, light sensitivity, and sound sensitivity. Chronic migraine can be disabling and may prevent many, especially women, from contributing to working life.



close
2.22736